Literature DB >> 2494361

Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.

D Larrey, P Marcellin, E Fréneaux, D Pessayre, J P Benhamou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2494361

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment.

Authors:  L Pacifici; F Passarelli; G Papa; L Cannone; P M Rossini
Journal:  Ital J Neurol Sci       Date:  1993-10

Review 3.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

Review 4.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.